Articles

A Belgian consensus protocol for autologous haematopoietic stem cell transplantation in multiple sclerosis

BJH - volume 9, issue 5, september 2018

A. Van de Velde MD, B. Willekens , L. Vanopdenbosch MD, O. Deryck , D. Selleslag MD, M. D’Haeseleer , A. De Becker MD, B. Dubois MD, PhD, D. Dierickx MD, PhD, G. Perrotta , V. De Wilde MD, PhD, V. Van Pesch MD, PhD, N. Straetmans MD, PhD, D. Dive MD, Y. Beguin MD, PhD, B. Van Wijmeersch MD, PhD, K. Theunissen , T. Kerre MD, PhD, G. Laureys MD, PhD

SUMMARY

Multiple sclerosis is considered to be an immune mediated inflammatory disorder of the central nervous system. It mainly affects young, socioeconomic active patients. Although our armamentarium for this disease has significantly evolved in recent years some patients remain refractory to conventional therapies. In these cases, autologous haematopoietic stem cell transplantation can be considered as a therapeutic option. Decreasing morbidity, mortality and increasing patient awareness have led to rising inquiry by our patients about this treatment option. With the aim of a standardised protocol and data registration, a Belgian working party on stem cell therapy in multiple sclerosis was established. In this paper, we report the consensus protocol of this working party on autologous haematopoietic stem cell transplantation in multiple sclerosis.

(BELG J HEMATOL 2018;9(5):167–74)

Read more

P4.05 Utility of next-generation sequencing in clinical practice: 5 cases diagnosed with primary myelofibrosis

BJH - volume 7, issue Abstract Book BHS, january 2016

N. Put MD, PhD, B. Maes MD, PhD, R. Achten , K. Deraedt , K. Theunissen , V. Madoe

Read more

O.3 Comparison of 2 nonmyeloablative regimens for allogeneic HCT: a phase II randomized study from the HCT committee of the BHS

BJH - volume 5, issue Abstract Book BHS, january 2014

F. Baron MD, PhD, P. Zachée MD, PhD, J. Maertens MD, PhD, T. Kerre MD, PhD, A. Ory , L. Seidel , C. Graux MD, PhD, P. Lewalle MD, PhD, H. Schouten , K. Theunissen , R. Schots MD, PhD, Y. Beguin MD, PhD

Read more

P3.05 Efficacy of azacitidine in Belgian patients: results of a real-life non-interventional, post-marketing survey

BJH - volume 5, issue Abstract Book BHS, january 2014

S. Meers MD, PhD, D. Selleslag MD, Y. Beguin MD, PhD, C. Graux MD, PhD, G. Bries MD, PhD, D. Deeren , I. Vrelust MD, P. Pierre , C. Ravoet , K. Theunissen , F. Trullemans , L. Noens MD, PhD, P. Mineur MD

Read more

P.67 Comparison of immune reconstitution after hematopoietic stem cell transplantation with FLU-TBI vs. TLI-ATG conditioning

BJH - 2013, issue BHS Abstractbook, january 2013

M. Hannon , S. Humblet-Baron , C. Graux MD, PhD, J. Maertens MD, PhD, T. Kerre MD, PhD, K. Theunissen , C. Daulne , E. Willems MD, PhD, L. Belle , M. Binsfeld , A. Gothot MD, PhD, Y. Beguin MD, PhD, F. Baron MD, PhD

Read more